AR220739A1 - Procedimiento para preparar 1-(p-metoxibenzoil)-2-pirrolidinona - Google Patents

Procedimiento para preparar 1-(p-metoxibenzoil)-2-pirrolidinona

Info

Publication number
AR220739A1
AR220739A1 AR22073979D AR22073979D AR220739A1 AR 220739 A1 AR220739 A1 AR 220739A1 AR 22073979 D AR22073979 D AR 22073979D AR 22073979 D AR22073979 D AR 22073979D AR 220739 A1 AR220739 A1 AR 220739A1
Authority
AR
Argentina
Prior art keywords
metoxibenzoil
pirrolidinone
preparing
procedure
Prior art date
Application number
AR22073979D
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR220739A1 publication Critical patent/AR220739A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AR22073979D 1978-02-10 1979-01-01 Procedimiento para preparar 1-(p-metoxibenzoil)-2-pirrolidinona AR220739A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140378 1978-02-10
CH1198178 1978-11-22

Publications (1)

Publication Number Publication Date
AR220739A1 true AR220739A1 (es) 1980-11-28

Family

ID=25687541

Family Applications (1)

Application Number Title Priority Date Filing Date
AR22073979D AR220739A1 (es) 1978-02-10 1979-01-01 Procedimiento para preparar 1-(p-metoxibenzoil)-2-pirrolidinona

Country Status (34)

Country Link
US (1) US4369139A (xx)
EP (2) EP0044088B1 (xx)
JP (1) JPS6059907B2 (xx)
AR (1) AR220739A1 (xx)
AT (1) AT374787B (xx)
AU (1) AU525514B2 (xx)
BG (1) BG29281A3 (xx)
BR (1) BR7900684A (xx)
CA (1) CA1100515A (xx)
CS (1) CS226182B2 (xx)
CU (1) CU21107A3 (xx)
DD (1) DD141828A5 (xx)
DE (1) DE2963321D1 (xx)
DK (1) DK155278C (xx)
EG (1) EG13873A (xx)
ES (2) ES477587A1 (xx)
FI (1) FI69063C (xx)
GR (1) GR71464B (xx)
HK (1) HK6185A (xx)
HU (1) HU177644B (xx)
IE (1) IE47831B1 (xx)
IL (1) IL56587A0 (xx)
IN (1) IN150106B (xx)
MC (1) MC1257A1 (xx)
MY (1) MY8500340A (xx)
NO (1) NO152046C (xx)
NZ (1) NZ189571A (xx)
OA (1) OA06180A (xx)
PH (1) PH15491A (xx)
PL (1) PL115958B1 (xx)
PT (1) PT69206A (xx)
RO (1) RO76615A (xx)
SU (1) SU931104A3 (xx)
YU (1) YU41330B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8004025A (nl) * 1979-08-09 1981-02-11 Hoffmann La Roche Pyrrolidinederivaten en werkwijze voor het bereiden daarvan alsmede geneesmiddel.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4398938A (en) * 1982-05-20 1983-08-16 Velsicol Chemical Corporation N-Acylated lactams and their herbicidal compositions and method of use
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
CH661174GA3 (xx) * 1985-07-10 1987-07-15
US4691853A (en) * 1985-12-30 1987-09-08 Technalytics, Inc. Surgical stapler
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
JP2585086B2 (ja) * 1988-12-28 1997-02-26 大鵬薬品工業株式会社 ジアザビシクロアルカン誘導体
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 1―フエノキシカルボニル―2―ピロリジノン誘導体
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
ATE253909T1 (de) * 1992-07-24 2003-11-15 Univ California Arzneimittel die den durch ampa rezeptoren vermittelten synaptischen response erhöhen
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
CA2212829A1 (en) * 1995-02-21 1996-08-29 Jiro Takeo Glutamic acid receptor agonist
FR2792833B1 (fr) * 1999-04-27 2002-09-06 Hoffmann La Roche Utilisation de l'acide n-anisoyl-gamma-aminobutyrique ou de l'acide p-anisique pour la preparation d'une composition pharmaceutique
US7608636B2 (en) 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
US8858594B2 (en) * 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
EP2604592B1 (en) 2011-12-12 2014-10-08 Zaklady Farmaceutyczne Polpharma SA A process for the purification of aniracetam by crystallisation from aqueous solutions
CN109651222A (zh) * 2018-12-21 2019-04-19 上海昊航化工有限公司 一种阿尼西坦的催化合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.

Also Published As

Publication number Publication date
HK6185A (en) 1985-02-01
DK56379A (da) 1979-08-11
YU41330B (en) 1987-02-28
AU4391679A (en) 1979-08-16
EP0005143B1 (de) 1982-07-14
FI69063B (fi) 1985-08-30
EP0044088A2 (de) 1982-01-20
GR71464B (xx) 1983-05-30
PL213340A1 (xx) 1980-03-24
YU28379A (en) 1983-02-28
MC1257A1 (fr) 1980-01-14
IL56587A0 (en) 1979-05-31
JPS54117468A (en) 1979-09-12
CU21107A3 (es) 1988-02-01
AU525514B2 (en) 1982-11-11
OA06180A (fr) 1981-06-30
NO152046C (no) 1985-07-24
ATA99579A (de) 1983-10-15
BR7900684A (pt) 1979-09-04
SU931104A3 (ru) 1982-05-23
NZ189571A (en) 1984-07-06
AT374787B (de) 1984-05-25
RO76615A (ro) 1981-04-30
PH15491A (en) 1983-01-31
EG13873A (en) 1982-12-31
IE790246L (en) 1979-08-20
ES483756A1 (es) 1980-04-16
EP0044088B1 (de) 1984-02-22
IN150106B (xx) 1982-07-24
DE2963321D1 (en) 1982-09-02
PT69206A (en) 1979-03-01
US4369139A (en) 1983-01-18
JPS6059907B2 (ja) 1985-12-27
FI69063C (fi) 1985-12-10
EP0005143A1 (de) 1979-11-14
IE47831B1 (en) 1984-06-27
NO152046B (no) 1985-04-15
ES477587A1 (es) 1980-01-16
EP0044088A3 (en) 1982-02-03
HU177644B (en) 1981-11-28
DD141828A5 (de) 1980-05-21
DK155278C (da) 1989-07-24
CS226182B2 (en) 1984-03-19
MY8500340A (en) 1985-12-31
NO790434L (no) 1979-08-13
FI790226A (fi) 1979-08-11
CA1100515A (en) 1981-05-05
DK155278B (da) 1989-03-20
BG29281A3 (en) 1980-10-15
PL115958B1 (en) 1981-05-30

Similar Documents

Publication Publication Date Title
AR220739A1 (es) Procedimiento para preparar 1-(p-metoxibenzoil)-2-pirrolidinona
AR230989A1 (es) Procedimiento para preparar acilureidoalquil-bencen-sulfonilureas
MX6255E (es) Procedimiento para preparar benzamidas substituidas
MX154095A (es) Procedimiento para preparar polieteres sililados
MX5973E (es) Procedimiento para preparar compuestos cefem
AR228341A1 (es) Procedimiento para preparar 6-n-propil etil u 8-metoxi-metil,metil-mercaptometilergolinas,alil-8-metoximetil o metilmercapto metil o metilsulfonilmetil-ergolinas
ES476994A0 (es) Procedimiento para preparar perhalociclopropanocarboxilatos.
MX5604E (es) Procedimiento para preparar aril-hidantoina
ES492255A0 (es) Procedimiento para preparar aroilimidazol-2-onas
AR231137A1 (es) Procedimiento para preparar metoxifenetilimidazoles
MX6816E (es) Procedimiento para preparar quinolonas
ES481478A0 (es) Procedimiento para preparar o-metaliloxifenol.
AR218563A1 (es) Procedimiento para preparar urea
MX7642E (es) Procedimiento para preparar la 1-ciclo-hexenilmentil-2-cloroetil pirrolidina
AR230624A1 (es) Procedimiento para preparar omega-arcil(propionil o butiril)-l-prolinas substituidas
MX6141E (es) Procedimiento para preparar acil-ureas
ES502851A0 (es) Procedimiento para preparar n6-adenosina
MX6405E (es) Procedimiento para preparar tiazolilideno-oxo-propionitrilos
MX6024E (es) Procedimiento para preparar 2-cloro-4-hidroximetil-tiazoles-5-substituidos
ES500738A0 (es) Procedimiento para preparar pirimidil-quinazolinas
MX6699E (es) Procedimiento para preparar acil-ureas
MX6807E (es) Procedimiento para preparar oxaquinolicidinas
AR217085A1 (es) Procedimiento para preparar 1-(n-acil-carbamoil)-2-cianaziridinas
AR226337A1 (es) Procedimiento para preparar kijanimicina
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina